Ad-Tech Medical Instrument
Private Company
Total funding raised: $9.2M
Overview
Ad-Tech Medical Instrument is a long-established, privately-held medical device company focused on developing and commercializing specialized intracranial electrodes for the diagnosis and surgical treatment of neurological diseases, primarily epilepsy. Founded in 1983 by a parent affected by neurological disease, the company has built a strong reputation for its proprietary electrode designs, including subdural grids/strips, depth electrodes, and related surgical accessories. In a significant strategic development, Ad-Tech was acquired by Nihon Kohden, a major Japanese medical electronics firm, a move aimed at solidifying comprehensive epilepsy diagnostics and care offerings globally.
Technology Platform
Proprietary designs for intracranial electrodes (subdural grids/strips, depth electrodes, foramen ovale electrodes) and unique connection systems for long-term EEG monitoring, brain mapping, SEEG, and brain stimulation.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Ad-Tech competes in the specialized niche of intracranial electrodes with other private medtech firms like PMT Corporation and Integra LifeSciences (which offers related neurosurgery tools). Its primary competitive advantage is its focused expertise and proprietary designs, now significantly bolstered by the backing and complementary technology portfolio of its parent company, Nihon Kohden, creating a more formidable integrated offering.